Antidepressants and pediatric depression--the risk of doing nothing.
Brent
David A
DA
Western Psychiatric Institute and Clinic, Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, USA.
D000293:Adolescent; D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology / Q000628:therapy; D004348:Drug Labeling / Q000331:legislation & jurisprudence; D005473:Fluoxetine / Q000009:adverse effects / Q000627:therapeutic use; D033161:Government Regulation; D006801:Humans; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D013405:Suicide / Q000639:trends; D014481:United States / Q000453:epidemiology; D014486:United States Food and Drug Administration; D000092864:Suicide Prevention
D000928:Antidepressive Agents; D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors